Loading provider…
Loading provider…
Neurology Physician in Carlsbad, CA
NPI: 1346276375Primary Practice Location
Premier Pharmacy Services
6010 Hidden Valley Rd, Carlsbad, CA
Primary Employer
North County Neurology Associates
neurocenter.com
HQ Phone
Get M.D Jack's Phone Numberphone_androidMobile
Get M.D Jack's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1982 - 2025

American Board of Psychiatry and Neurology
Neurology
University of California (San Diego) Medical Center
Residency • Neurology
1982 - 1985
UC San Diego School of Medicine
medschool.ucsd.edu
Medical School
Until 1981
Cedars-Sinai Medical Center
Internship • Internal Medicine
1981 - 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | J0585Injection, onabotulinumtoxina, 1 unit | 322 | 211,665 |
| 2 | 64615Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 236 | 652 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 106 | 125 |
| 4 | 95874Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | 88 | 245 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 53 | 57 |
Authors: Denise Chou, Elizabeth Faust, Alexander Feoktistov, Andrew Blumenfeld
Journal: Neurol Ther
Publication Date: 2021-04-15
Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlle...
Authors: Jack D Schim, Carlton Anderson, Elizabeth Brunner, Joe Hirman, Annette Ogbru
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers.
Authors: Denise Chou, Karen Yang, Shivang Joshi, Alexander Feoktistov, Zubair Ahmed
Publication Date: 2021-02-05
Lead Sponsor: AEON Biopharma, Inc.
Collaborators: PPD Development, LP
Intervention / Treatment: DRUG: Placebo, DRUG: ABP-450
Lead Sponsor: Theranica
Intervention / Treatment: DEVICE: Nerivio sham device, DEVICE: Nerivio active device
Lead Sponsor: Pharmalyte Solutions LLC
Collaborators: Clinvest
Intervention / Treatment: DRUG: Placebo, DRUG: MLD10